Lytic domain fusion constructs and methods of making and using same

Details for Australian Patent Application No. 2009206212 (hide)

Owner Esperance Pharmaceuticals Board of Supervisors of Louisiana State University and Agricultural and Mechanical College

Inventors Leuschner, Carola; Alila, Hector

Agent Wrays

Pub. Number AU-A-2009206212

PCT Pub. Number WO2009/094634

Priority 61/023,377 24.01.08 US

Filing date 26 January 2009

Wipo publication date 30 July 2009

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/59 (2006.01) Peptides having more than 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/094634 Priority application(s): WO2009/094634

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009206216-Methods and apparatuses for convective polymerase chain reaction (PCR)

2009206207-A hand held implement